Dabrafenib plus trametinib in patients with BRAFV600E-mutant low-grade and high-grade glioma (ROAR): a multicentre, open-label, single-arm, phase 2, basket trial-Reference-Cited by-同舟云学术

Dabrafenib plus trametinib in patients with BRAFV600E-mutant low-grade and high-grade glioma (ROAR): a multicentre, open-label, single-arm, phase 2, basket trial

Published:2022-01 Issue:1 Volume:23 Page:53-64
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Wen Patrick Y,Stein Alexander,van den Bent Martin,De Greve Jacques,Wick Antje,de Vos Filip Y F L,von Bubnoff Nikolas,van Linde Myra E,Lai Albert,Prager Gerald W,Campone Mario,Fasolo Angelica,Lopez-Martin Jose A,Kim Tae Min,Mason Warren P,Hofheinz Ralf-Dieter,Blay Jean-Yves,Cho Daniel C,Gazzah Anas,Pouessel Damien,Yachnin Jeffrey,Boran Aislyn,Burgess Paul,Ilankumaran Palanichamy,Gasal Eduard,Subbiah Vivek

Funder

Novartis Pharmaceuticals Corp

Publisher

Elsevier BV

Subject

Oncology

Reference45 articles.

1. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2013-2017;Ostrom;Neuro-oncol,2020

2. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary;Louis;Acta Neuropathol,2016

3. The 2021 WHO classification of tumors of the central nervous system: a summary;Louis;Neuro-oncol,2021

4. Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions;Wen;Neuro-oncol,2020

5. Diffuse infiltrating oligodendroglioma and astrocytoma;van den Bent;J Clin Oncol,2017

Cited by 223 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Translational Research Platform for Malignant Central Nervous System Tumors;Neurologia medico-chirurgica;2024-09-15

2. Predicting response to chemotherapy in brain tumor patients based on MRI features;Clinical Neurology and Neurosurgery;2024-09

3. Clinical Outcome of Patients with Epithelioid Glioblastoma Harboring BRAFV600E Mutation; A Single Institution Experience;South Asian Journal of Cancer;2024-08-29

4. Opportunities and Challenges of Small Molecule Inhibitors in Glioblastoma Treatment: Lessons Learned from Clinical Trials;Cancers;2024-08-29

5. The effects of dabrafenib and/or trametinib treatment in Braf V600-mutant glioma: a systematic review and meta-analysis;Neurosurgical Review;2024-08-22